“richard-pops” Archives

in
Entry Author Date Location
Side Effect Weighs on Early Results for Alkermes’ Schizophrenia Drug 06/29/17 Boston
Stifling Immigration Is “Retrograde”: Highlights From “What’s Hot” 05/17/17 Boston
Last Chance to Snag a Ticket for What’s Hot in Boston Biotech 05/10/17 Boston
Grab Your Ticket for What’s Hot in Boston Biotech on May 11th 05/03/17 Boston
Check Out What’s Hot in Boston Biotech on May 11: Saver Rate Ends Today 04/06/17 Boston
Alkermes Eyes FDA Nod After Retooled Study Yields Desired Results 10/20/16 Boston
Depression Trials Fail, Alkermes Sees Silver Lining. Investors Don’t. 01/21/16 Boston
Amid Neuroscience Renaissance, BlackThorn Quietly Builds a Business 12/23/15 San Francisco
J.P. Morgan 2015: Notes, Thoughts, And Conversations From the Vortex 01/16/15 National
Xconomy Boston’s Top Stories of Q2 2014: Editor’s Picks 07/01/14 Boston
East Coast Biotech Roundup: Sarepta, Alkermes, Boston Biotech, & More 04/25/14 Boston
Alkermes CEO Richard Pops on Building Big, Playing Well with Pharma 04/18/14 Boston
Alkermes Scores Phase 3 Win for Long-Lasting Schizophrenia Drug 04/08/14 Boston
Alkermes Nabs $250M It Doesn’t Need, But Could Fend Off Barbarians 01/13/14 Boston
East Coast Biotech Roundup: Sarepta, Zalicus, Alkermes, & More 11/15/13 Boston
How Alkermes Survived a Brush With Death 11/11/13 National
East Coast Life Sciences Roundup: Verdine, Ariad, Karyopharm, & More 10/11/13 Boston
East Coast Life Sciences Roundup: Alkermes, Ensemble, Sinai, & More 07/19/13 Boston
Alkermes Adds Cancer, MS Drugs To Growing Portfolio 07/17/13 Boston
East Coast Life Sciences Roundup: Epizyme, Alkermes, Ophthotech, & More 05/31/13 Boston
Alkermes Unveils Full Mid-Stage Data On Depression Drug 05/31/13 Boston
Some Bold Baseball and Biotech Picks for the 2013 Season 03/11/13 National
Poll: Which of These 10 New Drugs Is Priced Too High? 02/11/13 National
Biotech CEOs See Insurers as the New Boogeymen, Not FDA 01/07/13 National
Alkermes Aims for Psychiatric Drug That Won’t Pack on the Pounds 01/03/13 Boston
Who Are Biotech’s New Go-To Investment Bankers? 11/12/12 National
Who Should Life Science Pros Follow on Twitter? 09/24/12 National
Biotech Begins to Come of Age on Twitter 09/17/12 National
Join Us for BIO Tweetchat at 12:30 pm ET with John Maraganore 06/15/12 National
Who’s on Biotech’s Endangered Species List? Mid-Sized Drugmakers 05/21/12 National
Page 1 of 3 next page »